GRDN Strangle Strategy

GRDN (Guardian Pharmacy Services, Inc.), in the Healthcare sector, (Medical - Distribution industry), listed on NYSE.

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

GRDN (Guardian Pharmacy Services, Inc.) trades in the Healthcare sector, specifically Medical - Distribution, with a market capitalization of approximately $2.26B, a trailing P/E of 42.56, a beta of 0.09 versus the broader market, a 52-week range of 19.17-41.36, average daily share volume of 447K, a public-listing history dating back to 2016, approximately 3K full-time employees. These structural characteristics shape how GRDN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.09 indicates GRDN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 42.56 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.

What is a strangle on GRDN?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current GRDN snapshot

As of May 15, 2026, spot at $36.30, ATM IV 45.80%, expected move 13.13%. The strangle on GRDN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this strangle structure on GRDN specifically: IV rank is unavailable in the current snapshot, so regime-based timing for GRDN is inferred from ATM IV at 45.80% alone, with a market-implied 1-standard-deviation move of approximately 13.13% (roughly $4.77 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GRDN expiries trade a higher absolute premium for lower per-day decay. Position sizing on GRDN should anchor to the underlying notional of $36.30 per share and to the trader's directional view on GRDN stock.

GRDN strangle setup

The GRDN strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GRDN near $36.30, the first option leg uses a $38.12 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GRDN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GRDN shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$38.12	N/A
Buy 1	Put	$34.48	N/A

GRDN strangle risk and reward

Net Premium / Debit: N/A
Max Profit (per contract): Unbounded
Max Loss (per contract): Unbounded
Breakeven(s): None on modeled curve
Risk / Reward Ratio: N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

GRDN strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on GRDN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on GRDN

Strangles on GRDN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the GRDN chain.

GRDN thesis for this strangle

The market-implied 1-standard-deviation range for GRDN extends from approximately $31.53 on the downside to $41.07 on the upside. A GRDN long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. As a Healthcare name, GRDN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GRDN-specific events.

GRDN strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GRDN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GRDN alongside the broader basket even when GRDN-specific fundamentals are unchanged. Always rebuild the position from current GRDN chain quotes before placing a trade.

Frequently asked questions

What is a strangle on GRDN?: A strangle on GRDN is the strangle strategy applied to GRDN (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With GRDN stock trading near $36.30, the strikes shown on this page are snapped to the nearest listed GRDN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are GRDN strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the GRDN strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 45.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a GRDN strangle?: The breakeven for the GRDN strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GRDN market-implied 1-standard-deviation expected move is approximately 13.13%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on GRDN?: Strangles on GRDN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the GRDN chain.
How does current GRDN implied volatility affect this strangle?: Current GRDN ATM IV is 45.80%; IV rank context is unavailable in the current snapshot.